IMMUNEERING CORPORATION

Insiders Immuneering Corporation

Equities

IMRX

US45254E1073

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-09 EDT			5-day change	1st Jan Change
1.56 ^USD	-4.29%		0.00%	-78.78%

05-07	Immuneering Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-09	Immuneering Corporation Presents Preclinical Data At the American Association for Cancer Research Annual Meeting	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Immuneering Corporation Appoints Thomas J. Schall to Its Board of Directors	03-12	CI
Immuneering Corporation Appoints Mallory Morales as Chief Accounting Officer, Effective July 1, 2023	23-06-14	CI
Immuneering Appoints Harold E. Brakewood as Chief Business Officer	23-03-28	CI
Immuneering Corporation Appoints Leah R. Neufeld as Chief People Officer	22-10-20	CI
Immuneering Corporation Announces Committee Changes	22-09-19	CI
Immuneering Corporation Announces Executive Changes	22-07-25	CI
Immuneering Strengthens Board of Directors with the Appointment of Diana F. Hausman, M.D	22-01-18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW